Back
First Trust Indtls/PrdcrDurbAlphaDEX®ETF Vs. Halozyme Therapeutics Industry Stock Comparison
Buy
73
FXR
First Trust Indtls/PrdcrDurbAlphaDEX®ETF
Last Price:
79.46
Seasonality Move:
4.62%
Sell
35
HALO
Halozyme Therapeutics
Last Price:
42.56
Seasonality Move:
17.03%
Buy
73
First Trust Indtls/PrdcrDurbAlphaDEX®ETF (FXR)
is a Buy
Is First Trust Indtls/PrdcrDurbAlphaDEX®ETF a Buy, Sell or Hold?
- The current First Trust Indtls/PrdcrDurbAlphaDEX®ETF [FXR] share price is $79.48. The Score for FXR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- FXR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $42.57. The Score for HALO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FXR Stock Price Chart
What is First Trust Indtls/PrdcrDurbAlphaDEX®ETF's stock price today?
-
The First Trust Indtls/PrdcrDurbAlphaDEX®ETF share price today is $79.48
The current trend is moderately bullish and FXR is experiencing slight selling pressure.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $42.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
FXR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.23 | Buy |
Relative Strength Index (14 RSI): | 58.17 | Buy |
Chaikin Money Flow: | -9526 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (75.96 - 80.02) | Buy |
Bollinger Bands (100): | (69.66 - 77.08) | Buy |
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.04 | Sell |
Relative Strength Index (14 RSI): | 26.84 | Sell |
Chaikin Money Flow: | -3822578 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.96 - 58.72) | Sell |
Bollinger Bands (100): | (51.86 - 60.48) | Sell |
FXR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 80.51 | Sell |
20-day SMA: | 78.1 | Buy |
50-day SMA: | 76.35 | Buy |
200-day SMA: | 71.43 | Buy |
8-day EMA: | 79.77 | Sell |
20-day EMA: | 78.65 | Buy |
50-day EMA: | 76.57 | Buy |
200-day EMA: | 71.2 | Buy |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.27 | Sell |
20-day SMA: | 54.02 | Sell |
50-day SMA: | 55.85 | Sell |
200-day SMA: | 48.97 | Sell |
8-day EMA: | 52.24 | Sell |
20-day EMA: | 54.19 | Sell |
50-day EMA: | 55.13 | Sell |
200-day EMA: | 50.65 | Sell |
First Trust Indtls/PrdcrDurbAlphaDEX®ETF Earnings Growth & FXR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
First Trust Indtls/PrdcrDurbAlphaDEX®ETF Technical Analysis
Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Halozyme Therapeutics Technical Analysis
Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |